Joint Formulary & PAD

Aclidinium bromide (Eklira Genuair) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Aclidinium bromide (Eklira Genuair)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LAMA
Keywords :
LAMAs, antimuscarinic bronchodilators, respiratory, long-acting muscarinic antagonist
Brand Names Include :
Eklira Genuair
Important Information :

Combination with LABA recommended in COPD.

Prescribe by BRAND

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
4

Other Indications

Below are listed other indications that Aclidinium bromide (Eklira Genuair) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).

Committee Recommendations (1)

The locally preferred LAMA devices are as follows:

  • Spiriva Respimat (tiotropium soft mist inhaler). Re-usable device.
  • Incruse Ellipta (Umeclidinium DPI)
  • Seebri Breezhaler (Glycopyrronium DPI)
  • Eklira Genuair (Aclidinium DPI)

Devices should be prescribed by BRAND

See full COPD guidelines for more information